This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Market Hustle: Nasdaq Sees Biggest Falls Since 2011

NEW YORK (TheStreet) -- U.S. stocks suffered over Thursday's session as a two-day recovery was stopped short by heavy selling of high-momentum names in the technology and biotech sectors. The losses came even as data showed improvement in labor market conditions. A day earlier, stocks were lifted on the dovish tone of minutes from the latest Federal Reserve meeting.

  • The Dow Jones Industrial Average closed down 1.62% to 16,170.22 while the S&P 500 ended 2.09% lower to 1,833.08 -- both indices suffered their biggest falls in two months. Meanwhile, the Nasdaq was the worst hit, posting its biggest decline since November 2011. The index took off 3.1% to 4,054.11.
  • In technology, some of the heaviest-volume laggards included Facebook (FB) which took off 5.2% to $59.16, Yelp (YELP) which plummeted 10.9% to $63.47, and Zynga (ZNGA) which shed 6.9% to $4.07. In biotech, Gilead Sciences (GILD) dropped 6.7% to $65.90 while Alexion Pharmaceuticals  (ALXN) plunged 7.5% to $144.19.
  • In earnings news, Rite Aid  (RAD) surged 8.4% after posting fourth-quarter earnings that beat expectations by 2 cents at 6 cents a share. Bed Bath & Beyond (BBBY) was a top laggard in the S&P 500, slumping more than 6.2% after guiding fiscal first-quarter earnings to a lower-than-expected 92 cents to 96 cents a share.
  • JPMorgan  (JPM) and Wells Fargo  (WFC) will report first-quarter earnings before the market opens on Friday.
  • Sam Stovall, S&P Capital IQ's chief equity strategist, noted that the longer-term equity outlook remains bullish to him despite the recent stall in U.S. equity prices. The recent rotations out of small caps and biotech stocks may actually be wringing out the excess speculation in the market without upending the market as a whole, he explained. "While Q1 EPS estimates have stalled along with prices, EPS growth is expected to reaccelerate as the year progresses," said Stovall.
  • U.S. weekly jobless claims fell 32,000 in the week of April 5 to 300,000, lower than the average economist's estimate of 320,000. The last time initial claims were this low was May 12, 2007, when they were at 297,000. The four-week moving average also dropped, down 4,750. A separate government report showed that March import prices rose by a more-than-expected 0.6%.
  • In international markets, the Hang Seng closed 1.51% higher while the Nikkei was flat. The DAX was 0.55% lower while the FTSE was 0.10% higher.
  • U.S. markets closed higher on Wednesday after Alcoa  (AA) kicked-off the first-quarter season with an earnings beat and the release of the minutes of the latest meeting of the Federal Open Market Committee. Minutes from the Federal Reserve's March policy meeting indicated that members were concerned the market had overreacted to a hawkish-sounding forecast. Some even questioned whether there's been enough stimulus to support the economy. "The minutes add to the view private markets overestimated a hawkish move by the Fed. They clearly did not shift in that direction," said Dan Greenhaus, BTIG's chief strategist.

-- By Jane Searle and Andrea Tse in New York

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,637.06 +22.25 0.13%
S&P 500 1,948.18 +6.90 0.36%
NASDAQ 4,432.8020 +13.3240 0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs